Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

222402

Sigma-Aldrich

Methylguanidine hydrochloride

98%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
CH3NHC(=NH)NH2·HCl
CAS Number:
21770-81-0
Molecular Weight:
109.56
MDL number:
MFCD00012576
UNSPSC Code:
12352100
PubChem Substance ID:
24853329
NACRES:
NA.22
Pricing and availability is not currently available.

Quality Level

200

Assay

98%

form

solid

solubility

water: soluble 50 mg/mL, clear

functional group

amine

SMILES string

Cl.CNC(N)=N

InChI

1S/C2H7N3.ClH/c1-5-2(3)4;/h1H3,(H4,3,4,5);1H

InChI key

VJQCNCOGZPSOQZ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Methylguanidine hydrochloride can be used to prepare:
  • Biaryl derivatives as BACE1 inhibitors.[1]
  • Modified xylose, which is used in the synthesis of biodegradable composite hydrogels.[2]
  • Methylguanidinium borohydride ionic liquid, which is applicable as a hydrogen storage material.[3]

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302,H315,H319

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCK6789
MKCQ6942
MKCJ5802
MKCH4785
MKCF9952

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A non-covalent strategy for montmorillonite/xylose self-healing hydrogels
Qi X, et al.
Royal Society of Chemistry Advances, 5(51), 41006-41012 (2015)
Jared N Cumming et al.
Bioorganic & medicinal chemistry letters, 22(7), 2444-2449 (2012-03-07)
From an initial lead 1, a structure-based design approach led to identification of a novel, high-affinity iminohydantoin BACE1 inhibitor that lowers CNS-derived Aβ following oral administration to rats. Herein we report SAR development in the S3 and F' subsites of
Methylguanidinium borohydride: an ionic-liquid-based hydrogen-storage material
Doroodian A, et al.
Angewandte Chemie (International ed. in English), 49(10), 1871-1873 (2010)
Jovana Vušurović et al.
ChemistryOpen, 6(6), 739-750 (2017-12-12)
Interactions of ribonucleic acid (RNA) with guanidine and guanidine derivatives are important features in RNA-protein and RNA-drug binding. Here we have investigated noncovalently bound complexes of an 8-nucleotide RNA and six different ligands, all of which have a guanidinium moiety
Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor
Cumming JN, et al.
Bioorganic & Medicinal Chemistry Letters, 22(7), 2444-2449 (2012)
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service